Epoch Biosciences Company Profile

22:36 EDT 25th September 2018 | BioPortfolio

Epoch Biosciences is a biotechnology company that makes products and develops technologies to help scientists, clinicians, and physicians around the world perform genetic research to improve our lives and our environment. The Company's technologies allow our customers to perform rapid, accurate and cost-effective genetic analysis at the scale necessary to generate the massive amounts of genetic information being studied today.Epoch's technologies can be applied to genetic research, drug development and clinical diagnostics, including infectious disease, oncology, genetic disease and population screening to assess our risk of disease or to predict our response to drugs. Our products also have application in forensics, food testing, and environmental testing, including bio-warfare and bioterroism. Pioneering companies including Applied Biosystems, Third Wave Technologies, Millennium Pharmaceuticals, QIAGEN, and Celera Diagnostics use Epoch Biosciences' technology to address these efforts. The Company markets its products directly to end-users and through distributors that provide worldwide reach, and licenses its technologies to other companies for incorporation into their products. Epoch's scientific and management teams are committed to providing a continuing stream of innovations that provide an edge to people working at the forefront of discovery.


23rd Dr. SE #150
United States of America


Phone: 425-482-5555
Fax: 425-482-5550

News Articles [678 Associated News Articles listed on BioPortfolio]

Gut microbiota in adolescents and the association with fatty liver: the EPOCH study

ASC Biosciences, Inc. announces ad dates for first television commercial

About ASC Biosciences, Inc.ASC Biosciences, Inc. ("ASC" or the "Company") is a development stage biotechnology company with a proprietary adult stem cell platform capable Read more...

Strategic partnership forms between Taconic Biosciences and Cyagen Biosciences

A strategic partnership has been formed between Taconic Biosciences and Cyagen Biosciences — both global companies that generate custom genetically engineered rodent models and associated services.

SOLID BIOSCIENCES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Solid Biosciences Inc. to Contact The Firm

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Solid Biosciences Inc. ("Solid Biosciences" or th...

African Women for Biosciences Platform Launched

Women in biosciences remain grossly under represented in leadership and decision-making levels, limiting contribution of scientific research to national development. A new platform - the African Women...

Apricus Biosciences, Inc.: Apricus Biosciences Announces Proposed Public Offering

SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that ...


RADNOR, PA / ACCESSWIRE / May 23, 2018 / Kaskela Law LLC reminds Solid Biosciences, Inc. (NASDAQ: SLDB) ("Solid Biosciences" or the "Company") investors that a class action complaint has been filed...

Kuros Biosciences Ltd.: Kuros Biosciences appoints Strategic Advisory Board

Kuros Biosciences appoints Strategic Advisory Board Schlieren (Zurich), Switzerland, September 25, 2018 - Kuros Biosciences (SIX: KURN) today announced the formation of its Strategic Advisory Boar...

Drugs and Medications [17 Associated Drugs and Medications listed on BioPortfolio]

Epoch [NSE Products, Inc.]

Epoch Acne Medication Blemish Treatment

Nu skin epoch [Alberto-Culver USA Inc.]

Epoch Antiseptic Hand Sanitizer

Epoch [NSE Products, Inc.]

Epoch® Antiseptic Hand Sanitizer

Epoch [NSE Products, Inc.]

epoch Ava puhi moni Anti-Dandruff Shampoo

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

PubMed Articles [78 Associated PubMed Articles listed on BioPortfolio]

The effect of epoch length on time and frequency domain parameters of electromyographic and mechanomyographic signals.

The selection of epoch lengths affects the time and frequency resolution of electromyographic (EMG) and mechanomyographic (MMG) signals, as well as decisions regarding the signal processing techniques...

Reduced-dose EPOCH-R chemotherapy for elderly patients with advanced stage diffuse large B cell lymphoma.

The standard treatment in elderly patients with diffuse large B cell lymphoma (DLBCL) has not yet been finely established. We investigated the efficacy and safety of rituximab with a reduced-dose of E...

Emergent de Sitter Epoch of the Quantum Cosmos from Loop Quantum Cosmology.

The quantum nature of the big bang is reexamined in the framework of loop quantum cosmology. The strict application of a regularization procedure to the Hamiltonian, originally developed for the Hami...

Associations of volumes and patterns of physical activity with metabolic health in children: A multivariate pattern analysis approach.

Physical activity (PA) favorably affects metabolic health in children, but it is unclear how total volumes versus patterns (bouts and breaks) of PA relate to health. By means of multivariate pattern a...

What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force.

Although the results were disappointing from two recent clinical trials of amyloid-targeting drugs in mild-to-moderate AD, the trials provided information that will be important for future studies, ac...

Clinical Trials [51 Associated Clinical Trials listed on BioPortfolio]

A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R for Patients With Richter's Syndrome

This research study is evaluating the combination of a study drug, venetoclax, and a standard chemotherapy regimen, EPOCH-R, as a possible treatment for Richter's Syndrome. The drugs invo...

R-DA-EDOCH Versus R-CEOP90, w/o Upfront Auto-HSCT in Young Patients With Intermediate/High-risk DLBCL

Patients initially are randomized into 4 arms: Arm I: R-DA-EPOCH; Arm II: R-DA-EPOCH + auto-SCT; Arm III: R-CEOP90; Arm IV: R-CEOP90 + auto-SCT. Patients who achieved complete remi...

R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis

Purpose: to evaluate an efficacy of chemotherapy regimens R-DA-EPOCH-21 and R-mNHL-BFM-90 with and without autologous hematopoietic stem cells transplantation (auto-SCT) in newly diagnosed...

DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Rearranged HGBL

The prognosis of patients with "high-grade B cell lymphoma with cellular myelocytomatosis (MYC) and B cell lymphoma 2 (BCL2) and/or B cell lymphoma 6 (BCL6) rearrangements" (double hit (DH...

A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas

This is a randomized study of combination chemotherapy (EPOCH II) versus EPOCH II and immunotherapy with peripheral blood stem cells (PBSC) and IL-2 in patients with relapsed Hodgkin's and...

Companies [366 Associated Companies listed on BioPortfolio]

Epoch Biosciences Incorporated

Epoch Biosciences is a biotechnology company making products to help scientists around the world who perform genetic research to improve our lives and our environment. The Company's technologies facil...

Epoch Pharmaceuticals

Epoch Biosciences is a biotechnology company making products to help scientists around the world who perform genetic research to improve our lives and our environment. The Company's technologies facil...

Epoch Biosciences

Epoch Biosciences is a biotechnology company that makes products and develops technologies to help scientists, clinicians, and physicians around the world perform genetic research to improve our lives...

EPOCH Senior Living

EPOCH Senior Living is a regional provider of senior living options, offering independent and assisted living, skilled nursing and rehabilitation, and memory care. EPOCH Senior Li...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

More Information about "Epoch Biosciences" on BioPortfolio

We have published hundreds of Epoch Biosciences news stories on BioPortfolio along with dozens of Epoch Biosciences Clinical Trials and PubMed Articles about Epoch Biosciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Epoch Biosciences Companies in our database. You can also find out about relevant Epoch Biosciences Drugs and Medications on this site too.

Quick Search


Relevant Topic

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record